LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease

Clinical trial NCT04668898 · COMPLETED

Trial details

NCT number: NCT04668898
Sponsor: Icahn School of Medicine at Mount Sinai
Status: COMPLETED
Study type: OBSERVATIONAL

Parkinson Disease LRRK2 GBA Gene Mutation

Start date: 2019-04-01
Primary completion: 2025-04-01
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.